Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358
医学
无容量
易普利姆玛
内科学
肿瘤科
癌症
免疫疗法
作者
R. Wendel Naumann,Ana Oaknin,Tim Meyer,José M. López-Picazo,Christopher D. Lao,Yu Jeong Bang,Valentina Boni,William H. Sharfman,J.C. Park,Lot A. Devriese,Kenichi Harano,Christine H. Chung,Suzanne L. Topalian,Kam Zaki,Tai‐Tsang Chen,Junchen Gu,B. Li,Adam Barrows,Andrea Horváth,Kathleen N. Moore